AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $516,320 | -98.1% | 17,658 | -94.9% | 0.01% | -99.1% |
| Q3 2018 | $26,853,000 | -8.9% | 348,200 | -0.5% | 0.96% | -7.1% |
| Q2 2018 | $29,481,000 | -1.5% | 350,000 | -4.4% | 1.04% | -0.2% |
| Q1 2018 | $29,931,000 | +99.1% | 366,000 | +39.2% | 1.04% | +75.2% |
| Q4 2017 | $15,035,000 | +8.3% | 262,984 | +26.4% | 0.59% | -5.3% |
| Q3 2017 | $13,884,000 | +228.8% | 208,000 | +37.7% | 0.62% | +218.9% |
| Q3 2013 | $4,223,000 | – | 151,050 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |